Bayesian Capital Management, LP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$338,083
-30.7%
12,409
-55.8%
0.04%
-67.2%
Q3 2020$488,000
+111.3%
28,057
+44.6%
0.12%
+138.0%
Q1 2020$231,000
+50.0%
19,400
+52.8%
0.05%
+92.3%
Q4 2019$154,000
-45.8%
12,699
-13.6%
0.03%
-61.8%
Q3 2017$284,00014,7000.07%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders